A quarter of a million patients suffer due to economic blockade on Syria

After waiting for seven months, the patient Ibrahim received a kidney drug from the pharmacy of the Ministry of Health, which he is forced to take permanently after kidney transplantation in his right side.The long wait is because  the Western economic blockade against Syria impedes the arrival of many quality medicines, according to the Ministry of Health.

Ibrahim said that the economic sanctions on Syria have affected various aspects of our lives and prolonged our livelihood and medicine.

Another patient said that we can only obtain some medicines through the Ministry of Health centers because their price is high in privately owned  pharmacies. So we have to wait for them to be available and ask about them constantly. She summarized a reality that many patients live in light of economic sanctions. That caused the loss of some imported generic medicines, the increase in their prices, and being out of stock  for long periods.


From Deir Al-Zour, Mahmoud Mallouh Omar traveled  to obtain kidney medicine for his wife, who had undergone a kidney transplant since 2008. He noted that before the terrorist war on Syria, obtaining medicine was much easier than now and it was never delayed. But the economic sanctions and siege imposed by terrorist organizations on some areas, before their liberation, caused patients to be deprived of treatment and medicine. He added: "They trade in our pain and sufferings to weaken us.

The patients commended the efforts made by the Ministry of Health in ensuring the drugs they need.

According to the Director of Contagious and Chronic Diseases at the Ministry of Health  Dr. Jamal Khamis, the economic measures impeded the process of importing various types of chronic disease drugs. He indicated that the ministry provides some of these medicines through local production and others through friendly countries and United Nations organizations. The Ministry of Health provides free medicines to about 250,000 chronic patients.

Dr. Khamis, pointed out that the economic sanctions and the so-called (Caesar Act) imposed on Syria have also led to high costs and the difficulty of securing raw materials for local pharmaceutical industries and some packaging materials that are not manufactured locally.

Inas Abdulkareem